Trial intelligence / Profile preview

ClinOleic vs Intralipid in ARDS

NCT01096771Phase 2Terminated

Sponsor
Houston Methodist Research Institute
Start
Jun 2010
Primary completion
Nov 2012
Modality
Liposomes
Countries
1
01

Overview

A Phase 2 trial of Clinoleic in acute respiratory distress syndrome (ARDS), sponsored by Houston Methodist Research Institute. Started Jun 2010; status: terminated.

02

Drugs

Clinoleic
03

Conditions

acute respiratory distress syndrome (ARDS)

Beyond the preview

Go deeper on NCT01096771.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01096771.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call